Nuevolution A/S announces a new CEO
Nuevolution A/S announced that Knud Aunstrup is stepping down as the company's CEO and that he will be replaced in the position by Alex Haahr Gouliaev. The new management team of Nuevolution now comprises Alex Haahr Gouliaev (CEO), Henrik Pedersen (CSO) and Mark Payne (CFO).Knud Aunstrup will remain as an adviser to Nuevolution for the coming months.
Nuevolution's new CEO, Alex Haahr Gouliaev PhD (39), has a strong background as a medicinal chemist. Before joining Nuevolution as co-founder in 2001 with responsibility for Chemistry and Drug Discovery, he was Director of Chemistry and member of management at Denmark's largest biotech company, Neurosearch A/S.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.